tirzepatide mace Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist for type 2 diabetes: A systematic review and meta-analysis Cardiovascular outcomes. Forest plot comparing

Shima Hadidchi MD Family Practice Clinic, we are committed to supporting you throughout your weight loss journey

Ozempic and Zepbound may both be covered by insurance, but many insurers deny tirzepatide coverage, citing weight-loss indication exclusions or prior-authorization denials

Therapeutic relevance of GLP-1 Incretins are gut-derived peptide hormones released after nutrient ingestion that enhance glucose-dependent insulin secretion from pancreatic cells

The patent status of every drug in your competitive landscape directly affects formulary economics: a branded competitor that is 18 months from patent expiration cannot credibly commit to a three-year preferred formulary arrangement, because the PBM knows that a generic competitor will reset the pricing dynamic entirely within the contract period

This is where long-term planning matters